Vnitr Lek 2016, 62(4):243-245

Metformin u nemocných s 2. typem diabetes mellitus a laktátová acidóza - editorial

Jiří Charvát
Interní klinika 2. LF UK a FN v Motole, Praha

Received: November 12, 2015; Published: April 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Charvát J. Metformin u nemocných s 2. typem diabetes mellitus a laktátová acidóza - editorial. Vnitr Lek. 2016;62(4):243-245.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352(9131: 854-865. Erratum in Lancet 1998; 352(9139): 1558. Go to original source...
    2. Graham GG, Punt J, Arora M et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011; 50(2): 81-98. Go to original source... Go to PubMed...
    3. European Medicines Agency (EMA). Summary Information on a referral opinion Following an Arbitration Pursuant to Article 11 on Council Directive 75/319/EEC as Amended, for Glucophage/Glucophage Forte/Risidon/Dianben. Dostupné z WWW: <http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Glucophage_30/WC500011044.pdf>.
    4. National Institute for Health and Care Excellence (NICE). NICE Guidelines: the Management of Type 2 Diabetes. Dostupné z WWW: <http://www.nice.org.uk/guidance/cg87/chapter/guidance>.
    5. Glucophage (metformin hydrochloride) US Food and Drug. Administration website. Dostupné z WWW: <http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20357S019_Glucophage_prntlbl.pdf>.
    6. Canadian Diabetes Association (CDA) Clinical Practice Guideline. Pharmacologic Management of Type 2 Diabetes. Dostupné z WWW: <http://guidelinesdiabetes.ca/Browse/Chapter13>.
    7. Inzucchi SE, Lipska KJ, Mayo H et al. Metformin in Patients With Type 2 Diabetes and Kidney Disease: A systematic review. JAMA 2014; 312(24): 2668-2675. Go to original source... Go to PubMed...
    8. Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010; (4): CD002967. Dostupné z DOI: <http://dx.doi.org/10.1002/14651858.CD002967.pub4>. Go to original source... Go to PubMed...
    9. Frid A, Sterner GN, Londahl M et al. Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations. Diabetes Care 2010; 33(6): 1291-1293. Go to original source... Go to PubMed...
    10. Liu F, Lu JX, Tang JL et al. Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction. Chin Med J 2009; 122(21): 2547-2553.
    11. Lim VC, Sum CF, Chan ES et al. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Int J Clin Pract 2007; 61(11): 1829-1833. Go to original source... Go to PubMed...
    12. Duong JK, Roberts DM, Furlong TJ et al. Metformin therapy in patients with chronic kidney disease. Diabetes Obes Metab 2012; 14(10): 963-965. Go to original source... Go to PubMed...
    13. Davis TM, Jackson D, Davis WA et al. The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: the Fremantle Diabetes Study. Br J Clin Pharmacol 2001; 52(2): 137-144. Go to original source... Go to PubMed...
    14. Biradar V, Moran JL, Peake SL et al. Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit. Crit Care Resusc 2010; 12(3): 191-195. Go to original source... Go to PubMed...
    15. Seidowsky A, Nseir S, Houdret N et al. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009; 37(7): 2191-2196. Go to original source... Go to PubMed...
    16. Scott KA, Martin JH, Inder WJ. Acidosis in the hospital setting: is metformin a common precipitat? Intern Med J 2010; 40(5): 342-346. Go to original source... Go to PubMed...
    17. Runge S, Mayerle J, Warnke C et al. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab 2008; 10(1): 91-93. Go to original source...
    18. Scale T, Harvey JN. Diabetes, metformin and lactic acidosis. Clin Endocrinol 2011; 74(2): 191-196. Go to original source... Go to PubMed...
    19. Vecchio S, Giampreti A, Petrolini VM et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in retrospective case series of 66 patients on chronic therapy. Clin Toxicol 2014; 52(2): 129-135. Go to original source... Go to PubMed...
    20. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22(6): 925-927. Go to original source... Go to PubMed...
    21. Brown JB, Pedula K, Barzilay J et al. Lactic acidosis rates in type 2 diabetes. Diabetes care 1998; 21(10): 1659-1663. Go to original source... Go to PubMed...
    22. Eppenga WL, Lalmohamed A, Geerts AF et al. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care 2014; 37(8): 2218-2224. Go to original source... Go to PubMed...
    23. Richy FF, Sabidó-Espin M, Guedas S et al. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care 2014; 37(8): 2291-2295. Go to original source... Go to PubMed...
    24. Roussel R, Travert F, Pasquet B et al. Reduction of Atherorothrombosis for Continued Health (REACH) Registry Investigators. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010; 170(21): 1892-1899. Go to original source... Go to PubMed...
    25. Ekstrom N, Schioler L, Svensson AM et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open 2012; 2(4): e001076. Dostupné z DOI: <http://dx.doi.org/10.1136/bmjopen-2012-001076>. Go to original source... Go to PubMed...
    26. Hloch O, Charvát J, Masopust J et al. Lactic acidosis in medical ICU - the role of diabetes mellitus and metformin. Neuro Endocrinol Lett 2012; 33(8): 792-795. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.